Heart disease Clinical Trials in Dallas, TX
As of August 2026, 69 paid clinical trials are recruiting for Heart disease in Dallas, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
69 clinical trials for Heart disease
·Clear filters·EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Assessment of CCM in HF With Higher Ejection Fraction
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
SELUTION 4 De Novo Small Vessel IDE Trial
Global Paradise System US Post Approval Study
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Prevail Global Study
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
SPYRAL GEMINI Pilot Study
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection Fraction
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
The Fourth Left Atrial Appendage Occlusion Study
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Improving Veteran Referral to Cardiac Rehabilitation
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Home-based Cardiac Rehabilitation in Heart Failure
IEEM-Heat and Heart Failure
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Top Research Study Locations in Dallas
Researchers run research studies in Dallas, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Texas Southwestern Medical Center | Heart Failure, Prostate Cancer, Advanced Breast Cancer | 204 |
| UT Southwestern Medical Center | Hypertension, Obesity, Renal Cell Carcinoma | 176 |
| UT Southwestern/Simmons Cancer Center-Dallas | Malignant Solid Neoplasm, Stage IVB Prostate Cancer AJCC v8, Acute Myeloid Leukemia | 74 |
| University of Texas Southwestern | Cystic Fibrosis, Lymphoma, Non-Hodgkin, Multiple Myeloma | 62 |
| Baylor University Medical Center | Heart Failure, Interstitial Lung Disease, AML | 45 |
| The University of Texas Southwestern Medical Center | Anxiety, Breast Cancer, Depression Disorders | 28 |
| Parkland Memorial Hospital | Stage IIIB Lung Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8, Endometrial Clear Cell Adenocarcinoma | 27 |
| Medical City Dallas Hospital | Malignant Solid Neoplasm, Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | 24 |
| UT Southwestern Simmons Cancer Center - RedBird | Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Metastatic Renal Cell Carcinoma | 23 |
| Retina Foundation of the Southwest | Stargardt Disease, Age-Related Macular Degeneration, Amblyopia | 21 |
| Mary Crowley Cancer Research | Advanced Solid Tumor, Endometrial Cancer, Solid Tumor | 20 |
| UT Southwestern | AQP4+ NMOSD, Acute Kidney Injury, Advanced Endometrial Carcinoma | 20 |
| Baylor Scott & White Research Institute | Emphysema, Acute Respiratory Failure, Astrocytoma, Grade III | 19 |
| VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX | Cirrhosis, Heart Failure, Acute Kidney Injury | 19 |
| Zenos Clinical Research | Diabetic Peripheral Neuropathic Pain, Gout, Type 2 Diabetes | 17 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Chickenpox, HIV Infections | 15 |
| Methodist Dallas Medical Center | Achalasia, Acute Kidney Injury (AKI), BK Viremia | 14 |
| Texas Oncology - DFW | Breast Cancer, Endometrial Cancer, Pancreatic Cancer | 12 |
| Children's Medical Center Dallas | Niemann-Pick Type C Disease, Acute Kidney Injury, Acute Kidney Injury Due to Sepsis | 12 |
| Texas Oncology | Advanced Melanoma, Advanced Non-Small-Cell Lung Cancer, Advanced/Metastatic Solid Tumors | 12 |
| FutureSearch Trials of Dallas | Obesity, Overweight, Acute Treatment of Migraine | 10 |
| Methodist Dallas Medical Center- Clinical Research Institute | Trauma, Gastro-Intestinal Disorder, Chronic Pancreatitis | 10 |
| University of Texas Southwestern Medical Center at Dallas | Infant, Small for Gestational Age, Infant, Low Birth Weight, Infant, Newborn | 9 |
| Children's Medical Center | Neuroblastoma, Ewing Sarcoma, Osteosarcoma | 8 |
| Southwest Family Medicine Associates | Heart Failure, Atherosclerosis, Atherosclerotic Cardiovascular Disease (ASCVD) | 8 |
Active & Upcoming Studies in Dallas (2026)
Recruiting trials in Dallas grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (429 active studies)
- Molecular Breast Imaging (MBI)-Guided Biopsy · Smart Breast Corp.
- Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization · University of Colorado, Denver
Cardiovascular (125 active studies)
- Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · University of Texas Southwestern Medical Center
- Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure · Phase 3 · University of Texas Southwestern Medical Center
Neurology & pain (78 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Cholinergic Enhancement of Theta · EARLY_Phase 1 · University of Texas Southwestern Medical Center
Diabetes & metabolic (71 active studies)
Mental health & behavior (41 active studies)
- Optimizing CBSST With Executive Function Training for Schizophrenia (R33) · University of California, San Diego
- tDCS for Late-Life Depression · Andre Russowsky Brunoni
Eye & vision (31 active studies)
Pediatric (24 active studies)
- Comparing Surfactant Administration Through Supraglottic Airway and Thin Catheter for Preterm Infants · University of Texas Southwestern Medical Center
- Parent-Adolescent Relationships, Emotional Regulation, and HRV in Adolescents With Depression · University of Texas Southwestern Medical Center
HIV / STI (20 active studies)
Vaccines (6 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Common conditions studied in Dallas
- Heart Failure (32 active studies)
- Breast Cancer (31 active studies)
- Obesity (23 active studies)
- Prostate Cancer (20 active studies)
- Advanced Solid Tumor (19 active studies)
- Endometrial Cancer (16 active studies)
Leading research sponsors in Dallas
- University of Texas Southwestern Medical Center
- Baylor Research Institute
- Eli Lilly and Company
- AstraZeneca
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Dallas?
There are approximately 1,553 recruiting clinical trials in Dallas, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Dallas pay participants?
Most recruiting trials in Dallas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Dallas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Dallas?
The most common conditions under active study in Dallas include Heart Failure (32), Breast Cancer (31), Obesity (23), Prostate Cancer (20), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Dallas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Dallas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Dallas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Dallas?
Recruiting research sites in Dallas include University of Texas Southwestern Medical Center, UT Southwestern Medical Center, UT Southwestern/Simmons Cancer Center-Dallas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Dallas right now?
The largest active categories in Dallas are Cancer & tumors (429), Cardiovascular (125), Neurology & pain (78). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.